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Suboptimal sleep patterns predict poorer cognitive function in older adults, and induce 
inflammatory responses.   Inflammation could also adversely affect cognitive function.  This 
study explored whether inflammation may be one biological mechanism through which sleep 
influences follow-up cognitive performance.  Participants were 4877 men and women from the 
English Longitudinal Study of Ageing who were followed-up for 8 years starting at wave 4 
(2008-09), through wave 6 (2012-13), and until wave 8 (2016-17).  Sleep quality was indexed 
through self-report enquiring about difficulties falling asleep, waking up several times a night, 
and waking up in the morning feeling tired.  Sleep duration was ascertained by asking about 
average sleep duration in the weeknight.  Cognitive function was assessed with tests of verbal 
fluency, memory (immediate and delayed recall) and time orientation.  After adjustment for 
confounders, poor sleep quality at baseline predicted higher performance on time orientation 
at follow-up (β = 0.041, confidence interval (C.I.) 0.001 to 0.080) in women.  In men, in 
comparison with optimal sleep duration, short sleep measured at baseline predicted lower 
scores in delayed memory recall at follow-up (≤6 h: β = -0.334, C.I. -0.601 to -0.067; >6-7 h: 
β = -0.254, C.I. -0.496 to -0.012).  There was no evidence of mediating effects of inflammatory 
markers in the relationship between sleep measures and cognitive function in both sexes.  In 
conclusion, baseline poor sleep quality and short sleep duration are associated with follow-up 
cognitive function in older adults, but we found no evidence of any mediating effects of 
inflammatory markers.   
 





Poor sleep becomes increasingly prevalent with advancing age (Crowley, 2011), which 
adversely affects numerous aspects of physical and mental health.  For example, too short 
(typically defined as ≤5–6 h per night), too long (typically defined as >8 h per night) sleep, and 
sleep of poor quality increase the risk of cardiovascular outcomes and mortality (Cappuccio et 
al., 2011; Sofi et al., 2014), type 2 diabetes, obesity and hypertension (Jike et al., 2018; 
Schmid et al., 2015), as well as subsequent depression (Koyanagi et al., 2014; Zhai et al., 
2015).  This is particularly relevant for older adults, whose risk of physical and mental diseases 
and disability increases substantively with advancing age (Franco et al., 2009).   
Growing evidence seems to suggest that unhealthy sleep patterns also have an 
adverse impact on cognitive function.  Briefly, in the Whitehall II study, middle-aged adults, 
whose sleep duration either increased or decreased from 7-8 hours between baseline and 
follow-up assessments had lower performance on a number of cognitive tests such as 
reasoning, phonemic, and semantic fluency approximately 5 years later (Ferrie et al., 2011).  
Becoming either a short or longer sleeper, and extremes of sleep duration (≤5 or ≥9 hours) 
were also linked to poorer overall cognitive performance in the Nurses’ Health Study (Devore 
et al., 2014).  Similarly, a 22.5-year follow-up of the Finnish Twin cohort revealed that 
participants with short and long sleep hours had poorer performance on a cognitive test, which 
was calculated based on cognitive domains such as orientation, short and long term memory 
and attention (Virta et al., 2013).  However, a recent prospective analysis of the Doetinchem 
Cohort Study showed that long, but not short, sleep was predictive of a lower global cognitive 
function, memory and flexibility (van Oostrom et al., 2018).  Long and short sleep duration 
have also been found associated with lower cognitive function cross-sectionally (Blackwell et 
al., 2011; Faubel et al., 2009; Miller et al., 2014).  
Sleep duration does not capture other issues with sleep prevalent in older adults, such 
as difficulties with falling or staying asleep, yet few studies explored the prospective 
relationship between sleep disturbances with cognitive function.  For example, Virta et al. 
(2013) found that poor sleep quality predicted lower cognitive function scores at a 22.5-year 
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follow-up.  Cross-sectional studies in Denmark, the US, and the UK (Gadie et al., 2017; Nebes 
et al., 2009; Waller et al., 2016) found that disturbances of sleep measured with the Pittsburgh 
Sleep Quality Index (PSQI) were associated with a reduced performance on a range of 
cognitive tests.  In contrast, Blackwell et al. (2011) and Saint Martin et al. (2012) reported no 
associations between the PSQI and cognitive function.  Cross-sectional analysis of the English 
Longitudinal Study of Ageing (ELSA) revealed that greater sleep disturbances were found 
among participants with the highest scores on cognitive function tests (Miller at al., 2014). 
Although the evidence is limited, the few published studies that used objective sleep 
monitoring have also suggested that sleep is linked to cognitive function.  For example, a 
cross-sectional investigation of the Rotterdam study, which measured sleep with actigraphy, 
reported that longer sleep latencies were associated with poorer word memory recall and 
verbal fluency (Luik et al., 2015).  In the Osteoporotic Fractures in Men Study, which recorded 
sleep with in-home polysomnography, Blackwell et al. (2011) found that older men who spent 
more time awake after initially following asleep, and those with longer sleep durations, had 
lower scores on cognitive function tests than good sleepers.  A follow-up analysis of these 
data revealed that reduced time spent in REM sleep, and extended time spent in stage 1 
sleep, which are often found in older people, both predicted worse performance in cognitive 
function approximately 3.4 years later (Song et al., 2015).  
Experimental studies have also shown that sleep deprivation and disturbance of 
circadian rhythms, frequently reported in ageing adults, are associated with diminished 
cognitive function (Franzen et al., 2008; Santhi et al., 2016).   
Taken together, the current evidence suggests that suboptimal sleep patterns predict 
poorer performance on cognitive tests in older adults.  Several mechanisms have been 
proposed as possible mediators in this relationship, and there is a growing recognition that 
inflammation is one probable pathway through which sleep can adversely affect subsequent 
cognitive processes (Irwin and Vitiello, 2019; Yaffe et al., 2014).  Firstly, older age is 
associated with greater concentrations of inflammatory markers, which have been suggested 
to be a consequence of declining levels of sex hormones, and an increase in visceral adipose 
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tissue (see Singh and Newman, 2010, for a detailed review).  Secondly, a meta-analysis of 72 
observational studies comprising of over 50,000 adults reported that individuals with too short 
and poor sleep quality have elevated markers of inflammation (Irwin et al., 2016).  Thirdly, 
there is also some, albeit still limited, evidence that raised levels of inflammatory markers 
predict follow-up cognitive impairment (Bettcher and Kramer, 2014; Irwin & Vitiello, 2019).  
Specifically, relative to older adults with low levels of inflammation, those with high levels have 
been found to have a reduced volume of the hippocampus and medial temporal lobes.  
Inflammation also exerts a deleterious effect on vascular permeability, endothelial function, 
and microvascular structure, which subsequently affect white matter (see Bettcher and 
Kramer, 2014, for a review on this topic).  Recently, a prospective analysis of ELSA revealed 
that higher concentrations of CRP and fibrinogen both predicted worse performance on 
episodic memory tests (Tampubolon, 2016).  However, a different analysis of ELSA found no 
link between baseline CRP and a follow-up memory score 10 years later (Lassale et al., 2018). 
Very few studies to date have attempted to integrate the evidence on sleep, 
inflammation and follow-up cognitive function.  There is some evidence from animal research 
(Zhu et al., 2012) and clinical populations (Haensel et al., 2009) lending tentative support for 
the mediating role of inflammatory factors, but a 2-year follow-up of the Singapore-Longitudinal 
Aging Brain Study showed that CRP was unrelated to subsequent cognitive performance or 
sleep (Lo et al., 2014).  More longitudinal studies are needed to explore the relationship 
between baseline sleep, inflammation and follow-up cognition. 
In light of the limitations of the literature discussed above, the main aim of this study 
was to test whether inflammatory markers mediate the association between self-reported 
sleep and follow-up cognitive performance.  Based on the available evidence, we 
hypothesised that the association between baseline sleep and follow-up cognition would be 
stronger in women than in men, due to the association between sleep measures and 
inflammatory markers being potentially stronger in women.  Specifically, population-based 
studies have found that women, when compared with men, appear to be more vulnerable to 
the effects of poor sleep quality and too short sleep duration, and show higher increases in 
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inflammatory markers such as interleukin-6 and C-reactive protein (Irwin, 2015; Irwin et al., 
2016; Irwin and Vitiello, 2019).  Previous research has also demonstrated evidence for sex 
differences in the relationship between sleep and cognitive function, in both young and older 




Participants and procedures 
This article is based on data from the English Longitudinal Study of Ageing (ELSA) 
(Steptoe et al., 2013), which is a nationally representative study of men and women aged 50 
years and older living in England.  In ELSA data are collected biannually in participants’ home 
using a computer-assisted personal interview (CAPI) and a nurse visit a few days later, during 
which blood and other medical information are obtained. 
Analyses presented here are based on participants from waves 4 (2008-09), 6 (2012-
13) and 8 (2016-17).  Wave 4 is used here as the baseline since this was when sleep 
measures were introduced for the first time.  In ELSA, bloods were collected only during the 
nurse visits that are available at every other wave, and, to date, included waves 2, 4, 6 and 8; 
therefore, inflammatory markers described in our analyses were selected from waves 4 and 
6.  Wave 8 was chosen as this is the most recent data available in ELSA.  Inflammation, which 
was considered as a mediating factor in our analysis, was measured at wave 6, an  
intermediate time point of assessment selected temporally in the middle of the study period 
between exposure (wave 4) and outcome (wave 8). We selected this temporal order to 
investigate the deleterious effects of poor sleep quality, or too short sleep, subsequent 
inflammatory markers measured four years later, on follow-up cognition, measured another 
four years later.   
When we tried to restrict our analytical sample to participants who provided data on 
sleep, inflammation (CRP and fibrinogen), cognitive function and covariates at baseline, CRP 
and fibrinogen at wave 6, and cognitive measures at wave 8 this reduced the sample to 
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N=2548.  This would have reduced the statistical power and posed a threat of type II error; we 
would have also been prevented from running sex-stratified analyses.  The differences 
between participants with complete data on all variables, and those with missing data on one 
or more variable are detailed in the Statistical approach section.  We, therefore, decided to 
restrict our analytical sample to participants with complete baseline data on all covariates, 
sleep measures, inflammatory factors and cognitive function variables (N=4877).  However, 
as part of our sensitivity analyses, we repeated our mediation models on participants with 
complete data on waves 4,6 and 8, and the results were largely unchanged.    
Signed consent was obtained from all participants, and ethical approval was issued by 




All measures described here were obtained during the CAPI.  Socio-economic 
circumstances were estimated by total household wealth taking into account financial wealth 
(e.g., savings), the value of any property (less mortgage), and the value of any business assets 
and physical wealth (e.g., artwork), net of debt.  Wealth was divided into quintiles for these 
analyses.  Educational attainment was categorised into 6 categories: “degree level education”, 
“lower than degree education”, “GCE (General certificate of education) A-level equivalent 
education”, “up to GCE/O-level education”, “foreign or other qualification” and “no formal 
qualifications”.  Age was included as one of our socio-demographic measures as well.  These 
variables were selected for our analysis based on previous research findings indicating their 
relevance to sleep (Arber et al., 2009; Stranges et al., 2008), cognitive function (Cagney and 
Lauderdale, 2002), and inflammation (Koster et al., 2006). 
 
Sleep measures 
Sleep quality was indexed with three questions from the Jenkins Sleep Problems Scale 
(Jenkins et al., 1988): difficulties falling asleep, waking up several times a night, and waking 
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up in the morning feeling tired.  Participants answered these questions with regards to the 
past month (anchored at 1 = “not during the past month” to 4 = “three or more times a week”).  
Scores were averaged (range 1-4) with higher scores indicating poorer sleep quality.  The 
Cronbach’s alpha at wave 4 for this analytical sample was 0.60. 
Sleep duration was measured by asking participants about their average sleep 
duration on a weeknight.  For the analyses described here, sleep duration was categorised 
into “≤6 h” (short sleep duration), “>6-7 h”, and “>7-8 h” (optimal sleep duration).  We initially 
split short sleep hours into “≤5 h” and “>5-6 h”, but since only N=594 participants reported 
sleeping 5 or fewer hour, as to increase statistical power, we combined them with those 
reporting “>5-6 h”; this gave us N=1527 for the “≤6 h” category.  In our analytical sample, we 
only had N=327 participants who reported long sleep hours (“>8 h”).  To avoid type II error, 
we do not report findings for this sleep category.  This small number of cases would have also 
affected the power of our sex-stratified analyses. 
 
Biological data  
Blood samples were obtained during the nurse visit.  Blood samples were not taken 
from participants who had clotting disorders, or who were taking anti-coagulant medication.  
C-reactive protein was analysed using the N Latex C-reactive protein mono immunoassay on 
the Behring Nephelometer II analyser.  Fibrinogen concentrations were quantified using a 
modification of the Clauss thrombin clotting method on the Organon Teknika MDA 180 
analyser (Craig et al., 2006).  All blood samples were analysed in the Royal Victoria Infirmary 
laboratory in Newcastle upon Tyne, UK. 
 
Cognitive function measures  
Cognitive function was measured at wave 8 (2016-17) with verbal fluency, memory as 
well as orientation, which are the main cognitive measures administered in ELSA at each wave 
(Steptoe et al., 2013). 
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Verbal fluency was measured with animal naming, a task reflecting executive function.  
The test measures how quickly participants can think of words from a particular category, 
counting how many distinct elements from the animal kingdom (real or mythical, excluding 
repetitions or proper nouns) the respondent can name within one minute.  This test requires 
self-initiated activity, organisation, abstraction and set-shifting abilities (Steel et al., 2004).  In 
our study, the total number of correctly named animals represented the measure of verbal 
fluency, with a higher score representing a superior executive function. 
Memory was measured with a word recall test.  A random ten-word list was read by a 
computer with the speed of one word every two seconds.  Participants were required to 
remember as many words as they could, immediately and after a short delay.  We used the 
independent measures of immediate and delayed recall (with scores ranging on each task 
from 0 to 10), with higher scores indicating better immediate and delayed memory. 
Time orientation was assessed using questions relating to day and date from the Mini-
Mental State Examination (Folstein et al., 1975).  Higher scores reflect superior performance. 
 
Health-related variables  
Participants were requested to indicate whether they had any chronic illnesses or 
disability.  Those who indicated having an illness/disability were further asked whether their 
condition(s) limited their activities.  The response was then stratified into ‘‘yes’’ for limiting 
long-standing illness, and ‘‘no’’ for the absence of limiting long-standing illness.  Information 
on limiting long-standing conditions was included in our analysis because of the well-
established links with sleep (Zee and Turek, 2006), cognitive function (Juster et al., 2010), and 
inflammation (Singh and Newman, 2010).  Height and weight were assessed by the nurse and 
were used to calculate body mass index (BMI, kg/m2).  Data on smoking were collected by 
asking respondents whether they have ever smoked, and those who responded positively 
were further asked to state if they still smoked.  Responses were classified into “no” for 
never/past smokers and “yes” for current smokers.  Physical activity was indexed by asking 
whether respondents participated in mild, moderate and vigorous physical activity.  For the 
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analyses described here, we categorised responses into “moderate or vigorous physical 
activity less than once per week” and “moderate or vigorous physical activity at least once per 
week”.  Alcohol consumption was measured by asking respondents how many times they had 
an alcoholic drink in the last 12 months.  In this article responses were categorised into “5-6 
days a week or daily” and “less than daily”.  The above health-related variables were selected 
for our analyses because of their well-documented associations with sleep (Stranges et al., 
2008), cognitive function (Sabia et al., 2008), and inflammation (McDade et al., 2006). 
Depressive symptoms were assessed with an 8-item version of the Centre for 
Epidemiologic Studies Depression scale (CES-D) initially modified for the Health and 
Retirement Study in the US (Steffic, 2000).  For our analyses, the item concerning sleep was 
removed from the CES-D, to avoid the issue of shared variance with the measure of sleep 
quality.  The 7-item scale was answered with a “yes” or “no” response.  Scores were totalled 
(range 0-7) and greater scores were reflective of higher depressive symptoms.  The 
Cronbach’s alpha for the scale at wave 4 was 0.80.  We included depressive symptoms in our 
study since they are closely linked with sleep (Sofi et al., 2014; Koyanagi et al., 2014), 
cognitive function (Singh-Manoux et al., 2010), and inflammation (Howren et al., 2009). 
 
Statistical analysis  
Data were inspected descriptively and graphically.  Descriptive statistics were 
calculated with t tests and chi-square tests, as appropriate.  All analyses were performed using 
IBM’s Statistical Package for the Social Sciences (SPSS), version 21. 
C-reactive protein data were skewed at waves 4 and 6, and their distribution was 
normalised prior to analysis.  In this article, CRP was treated as a continuously distributed 
measure.  C-reactive protein levels of ≥10 mg/L are indicative of an acute inflammatory 
response or infection (Pearson et al., 2003), participants above this cut-off point were therefore 
excluded from analysis. 
In comparison with participants who had complete data on all variables used in our 
analyses (waves 4, 6 and 8, N=2548) those with missing information were older (P<0.001), 
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more likely to be in the lowest wealth quintile (P<0.001), and to have no formal qualifications 
(P<0.001).  With regards to health-related variables, participants with missing data were less 
likely to exercise moderately and vigorously more than once per week (P<0.001), and they 
were more likely to currently smoke (P<0.001).  They also had a slightly higher BMI (P=0.005), 
were more likely to have elevated depressive symptoms (P<0.001), and report a limiting 
chronic illness (P<0.001).   
All analyses were adjusted for age, wealth, educational attainment, smoking status, 
alcohol consumption, physical activity, BMI, limiting long-standing illness and depressive 
symptoms since these are related to sleep and cognitive function, as described in the 
Measures section.  Our models were also adjusted for baseline CRP, fibrinogen and the 
corresponding test on cognitive performance. 
Mediation analysis was performed using the PROCESS package (version 3) for SPSS 
(Hayes, 2018).  Baseline sleep measure at wave 4 was the exposure factor, an inflammatory 
variable at wave 6 was the potential mediator, and cognitive function at wave 8 was the 
outcome variable.  In our analyses, the total effect (c, see Tables 2-5) is the sum of the direct 
and indirect effect of the sleep measure on cognitive function.  The direct effect (c’, see Tables 
2-5) is the effect of the sleep measure on cognitive function after adjustment for an 
inflammatory factor.  Finally, the indirect effect (ab, see Tables 2-5) is the effect of our sleep 
measure on cognitive function through an inflammatory factor (Field, 2018).  See Fig. 1 below 
depicting the conceptual model tested in our study.  Separate analyses were performed for 
CRP and fibrinogen, and sleep quality and duration.  All mediation analyses were also 
repeated in the sample with complete data on all variables used in the study (N=2548).  These 
are reported in the Sensitivity analysis section, while tables are presented as supplementary 
material.  Results are presented as unstandardized coefficients and 95% confidence intervals 
(95% C.I.).  For indirect effects, 95% confidence intervals (C.I.) were calculated using 
bootstrapping, with 5000 bias-correcting (Bc) bootstrap samples (5000 is a default option in 
the PROCESS package version 3) (Hayes, 2018).  As recommended by Field (2018) and 
Hayes (2018) we used 95% C.I. (for direct and total effects) and Bc 95% C.I., (for indirect 
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effects), rather than p-values, to infer whether the observed effects were statistically 
significant. 
 
Insert Fig.1 around here 
 
Results 
Baseline participants’ characteristics   
Men were more likely than women to have a degree, and had slightly more wealth (see 
Table 1).  In terms of health-related variables, considerably more men than women drank 
alcohol daily, but more women reported a long-standing limiting, and had higher levels of 
inflammatory markers.  Women also reported more sleep and depressive symptoms than men, 
and more women were short sleepers.  However, women performed better on all cognitive 
tests included in the study. 
Insert Table 1 around here 
Sleep quality, CRP and cognitive function   
In women, baseline sleep quality was predictive of better time orientation (total effect: 
β = 0.041, C.I. 0.001 to 0.080) at follow-up, but there was no evidence of the mediating effect 
of CRP (indirect effect: β = -0.000, Bc C.I. -0.001 to 0.001) (see Table 2).  Sleep quality was 
unrelated to verbal fluency, and immediate and delayed recall.  There was no evidence that 
CRP had any mediating effect in these relationships. 
In men, sleep quality was not predictive of any cognitive function test 8 years later, and 
there was also no evidence of any mediating effect of CRP.  
Insert Table 2 around here 
Sleep quality, fibrinogen and cognitive function   
In women, sleep quality did not predict any cognitive function test, and there was no 
evidence of any mediating effects of fibrinogen (see Table 3).  
In men, as already reported with regards to CRP, sleep quality was unrelated to follow-
up cognitive function, and there was no evidence of any mediating effects of fibrinogen. 
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Insert Table 3 around here 
 
Sleep duration, CRP and cognitive function  
 As shown in Table, 4 in women sleep duration was unrelated to follow-up cognitive 
function, and there was no evidence of any mediating effect of CRP.   
 In men, however, short sleep duration (≤6 h) was predictive of a lower score on the 
delayed recall test (total effect: β = -0.303, C.I. -0.571 to -0.034), but this was not mediated by 
CRP levels (indirect effect: β = -0.000, Bc C.I. -0.010 to 0.009).   Sleep duration was unrelated 
to any other cognitive function test, and CRP had no mediating effect on the relationship 
between sleep hours and cognitive scores.  
Insert Table 4 around here 
Sleep duration, fibrinogen and cognitive function  
 In women, there was no evidence that sleep duration was associated with cognitive 
function 8 years later (see Table 5), and sleep duration did not have any impact on follow-up 
cognition through fibrinogen as well.  
 In men, in comparison with optimal sleep duration (>7-8 h), those sleeping ≤6 hours 
(total effect: β = -0.334, C.I.-0.601 to -0.067) and >6-7 hours (total effect: β = -0.254, C.I.  
-0.496 to -0.012) had worst performance on the delayed recall test at follow-up.  However, 
fibrinogen concentrations did not mediate these associations (indirect effect for ≤6 h: β = 
0.000, Bc C.I. -0.010 to 0.009; indirect effect for >6-7h: β = 0.000, Bc C.I. -0.008 to 0.007, 
respectively). 
Insert Table 5 around here 
Sensitivity analyses  
Results from sensitivity analyses broadly confirmed our main findings.  In women, 
baseline sleep quality was predictive of better time orientation at follow-up in models relating 
CRP (total effect: β = 0.046, C.I. 0.009 to 0.082) and fibrinogen (total effect: β = 0.046, C.I. 
0.009 to 0.082), but there was no evidence of mediating effects of either of the inflammatory 
marker (see Supplementary Table 1 and 2).  There was also no prospective association 
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between sleep quality and other cognitive tests.  Baseline sleep duration was unrelated to 
cognitive scores at follow-up, and there was no evidence of any mediating effects of 
inflammation.  
In men, baseline sleep quality was unrelated to cognition at follow-up, and there was 
no evidence of any mediation by CRP or fibrinogen.  In comparison with the >7-8 h sleep 
category, men sleeping ≤6 hours had lower scores on the delayed recall test in the model with 
CRP (total effect: β = -0.315, C.I. -0.584 to -0.045).  In the analysis relating fibrinogen men 
sleeping ≤6 hours (total effect: β = -0.316, C.I. -0.585 to -0.046) and >6-7 hours (total effect: 
β = -0.175, C.I. -0.419 to -0.070), in comparison with the >7-8 h sleep category, also had 
poorer performance on the delayed recall test at follow-up.  However, there was no evidence 
of any mediating effects of the inflammatory markers (see Supplementary Table 3 and 4).  
Baseline sleep duration was unrelated to the other three cognitive tests measured in our study, 
and there was no evidence of any mediating effects of inflammation.  
 
Discussion  
 We found that in women baseline sleep quality was predictive of greater time 
orientation at follow-up.  In men, those reporting short sleep hours at baseline (≤6 h, and >6-
7 h) were more likely to have lower scores on verbal memory at follow-up, especially in delayed 
recall, when compared with the optimal sleep category (>7-8 h).  None of the associations 
between sleep measures and follow-up cognitive function reported here was mediated by 
inflammatory factors, thus our research hypothesis was unsupported by our data.  
 Our finding that poorer sleep quality at baseline predicted better performance on time 
orientation corroborates a cross-sectional analysis of ELSA (Miller et al. 2014).  This is, 
however, in contrast with the study by Virta et al. (2013) where disturbed sleep was linked to 
worst cognitive performance approximately 22 years later.  We do not have a strong 
explanation for this rather counterintuitive finding.  One possibility could be that participants 
who perform better on cognitive function tests were also able to record their sleep more 
accurately, given that prior evidence suggested that poor cognitive function has been found to 
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adversely influence the level of agreement between self-reported and actigraphy-based sleep 
data in older adults (Van Den Berg et al., 2008).  However, while a poor cognitive function 
may impact on how sleep is reported if both measurements are taken at the same time, as 
was done by Van Den Berg and colleagues (2008), this is unlikely to be the case in our study 
in which baseline sleep and follow-up cognition were measured 8 years apart. 
 We found that men, but not women, in the ≤6 h and >6-7 h sleep categories had lower 
scores on the delayed recall test 8 years later.  This supports the hypothesis that sleep plays 
an active role in memory consolidation (Kreutzmann et al., 2015), and shows for the first time, 
to the best of our knowledge, the importance of sleep for delayed memory in older adults.  
Most previous studies looking at sleep and cognitive function did not look separately at 
delayed or immediate recall, but used an overall memory score, or computed a global cognitive 
function index from various cognitive tests.  Our overall findings are in line with a number of 
these studies.  For example, an earlier cross-sectional analysis of ELSA found that short sleep 
was associated with lower scores on cognition, albeit only among those aged 64 or younger 
(Miller et al., 2014).  Regarding prospective findings, our study supports data obtained by Virta 
et al. (2013) whereby short sleep predicted lower cognitive scores in men and women aged 
65 years on average.  We also corroborate a study in which short sleep predicted a decline in 
cognitive performance of older Chinese men and women (Lo et al. (2014).  In the Nurses’ 
Health study, composed solely of female participants, short sleep also predicted poor cognitive 
performance (Devore et al., 2014).  This is at odds with our data since we only found the 
relationship in men, but not women.  Finally, our finding that short sleep predicts lower scores 
on the memory delayed recall test, when compared with optimal sleep duration, does not 
support recent prospective analysis of the Doetinchem Cohort Study (van Oostrom et al., 
2018) in which short sleep was unrelated to subsequent cognitive performance.  
One possibility why baseline short sleep duration predicted lower performance on the 
delay memory recall test in men, but not women, at follow-up, could be because we lacked 
statistical power to also detect this relationship in women.  This does not seem to be the case 
since, in our data, more women than men were short sleepers.  However, in our study men 
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had lower scores on all cognitive tests including the delayed recall memory test.  Notably, sex 
differences in cognition have been reported previously, including in ageing adults (De Frias et 
al., 2006).  Although we adjusted our analysis for baseline cognition and other confounders 
that could potentially impact follow-up cognition, we cannot rule out the possibility that the 
association between baseline sleep duration and follow-up cognition was a result of a third 
unmeasured variable.  
A number of experimental studies of sleep deprivation conducted in rodents and 
humans have documented the importance of sleep duration for effective memory 
consolidation.  Sleep quality also appears to be important, and clinical data from patients with 
insomnia suggest that poor sleep quality correlates with a diminished sleep-related 
consolidation of declarative memory (Kreutzmann et al., 2015).  Hypoxia and disturbed 
neuronal activity are also plausible mechanisms through which too short or poor quality sleep 
might impair cognitive functioning in older adults.  Circadian rhythms affect activity in frontal, 
thalamic, and hypothalamic regions of the brain, impairing learning and memory (Yaffe et al., 
2014).  Furthermore, as far as memory consolidation is concerned, human neuroimaging 
studies suggest that the brain region that appears to be particularly sensitive to the 
consequences of sleep loss or its poor quality is the hippocampus (Kreutzmann et al., 2015).   
In our data, the prospective association between sleep quality and duration with follow-
up cognitive function was not mediated by inflammatory factors, namely CRP and fibrinogen.  
In a study of older Chinese adults CRP was also unrelated to sleep and cognitive function (Lo 
et al., 2014), albeit the authors did not perform a mediation analysis, so our findings cannot 
be directly compared with that data.  Greater levels of inflammatory factors have been found 
associated with reduced cognitive function in patients with obstructive sleep apnoea (Haensel 
et al., 2009), and in animal studies of acute sleep deprivation (Zhu et al., 2012).  This raises 
the possibility that more severe sleep disturbances than reported by our participants are 
needed to raise inflammation, which could then adversely affect cognition.  More studies are 
warranted to explore if inflammation may be translating the deleterious impact of aberrant 
sleep on follow-up cognition in community-dwelling older adults.  
17 
 
 The strengths of our study include a prospective design of (older) adults who are 
chosen to be representative of men and women living in England.  Since a large number of 
data are collected as part of ELSA, this minimises the risk that participants are aware of 
researchers’ interests such as sleep and cognitive function described here. 
 Our findings must be interpreted in light of the limitations of our data.  Sleep was 
measured by self-report, and estimations of sleep quality (Jackowska et al., 2011) and 
duration (Lauderdale et al., 2008) are imprecise when compared with sleep data measured 
objectively.  Factors that may influence people’s perceptions of sleep include, for example, 
age, fewer years of education and work stress (Jackowska et al., 2011; Lauderdale et al., 
2008).  We also do not have information about sleep disorders, such as sleep apnoea and 
insomnia, since these were not collected in wave 4 of ELSA that was our baseline, but all 
analyses were adjusted for the presence of limiting long-standing illness, smoking, BMI and 
depressive symptoms, which are relevant for these disorders.  Attrition is a well-known issue 
in longitudinal studies including ELSA, and participants excluded from our analyses were 
older, more likely to have no formal qualifications; they also reported more depressive 
symptoms and limiting long-standing illnesses.  Furthermore, at the time of these analyses 
ELSA did not have up-to date mortality records.  However, sensitivity analyses performed on 
the sample with complete data on all variables used in the study (N=2548) fully confirmed the 
findings from our analytical sample (N=4877).  Due to a small number of participants in the 
long sleep category (8> h) in our analytical sample, we decided to exclude it from our analysis 
in order to avoid the risk of type II error.  This, regrettably, prevents us from comparing our 
data with previous findings where long sleepers have been found to score lower on cognitive 
function tests (Devore et al., 2014; van Oostrom et al., 2018; Virta et al., 2013). 
 In conclusion, our study adds to the body of evidence that adverse sleep patterns are 
prospectively associated with cognitive performance in the elderly.  We found that women who 
were reporting poorer sleep quality performed better on the time orientation test than those 
reporting fewer sleep complaints.  In men, in comparison with optimal sleep duration, short 
sleepers had lower scores on the delayed recall memory test.  However, inflammatory factors 
18 
 
did not mediate the prospective association between sleep and cognitive performance 
reported here.  Nevertheless, this work opens up possibilities for exploring other mechanistic 
ways in which a range of modifiable risk factors, such as good sleep, might enhance cognitive 
functioning in people at older ages, for the possible improvement of health, and social function 
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Table 1. Baseline participants characteristics (N=4877).  
Variable  Mean (SD)/N (%)  
 Men (N=2203) Women (N=2674) P-value  
Age  65.4 (8.8) 65.8 (9.3) 0.101 
Education attainment      <0.001 
     Degree 548 (24.9) 396 (14.8)  
     Less than a degree 447 (20.3) 341 (12.8)  
     GCE A-level/equivalent 203 (9.2) 219 (8.2)  
     Up to GCE/O-level 490 (22.2) 676 (25.3)  
     Foreign or other qualification 






Wealth quintiles    0.001 
     Poorest quintile 273 (12.4) 391 (14.6)  
     2nd quintile 366 (16.6) 517 (19.3)  
 3rd quantile 447 (20.3) 561 (21.0)  
     4th quantile  530 (24.1) 563 (21.1)  
  Richest quintile 587 (26.6) 642 (24.0)  
Current smoking status   0.157 
      No 1949 (88.5) 2330 (87.1)  
      Yes 254 (11.5) 344 (12.9)  
Alcohol consumption   <0.001 
  5-6 days a week or daily 640 (29.1) 467 (17.5)  
      Less than daily 1563 (70.9) 2207 (82.5)  
Moderate or vigorous physical 
activity 
  <0.001 
     Less than once per week 582 (26.4)   939 (35.1)  
     At least once per week 1621 (73.6) 1735 (64.9)  
BMI (kg/m2) 28.0 (4.3) 28.0 (5.5) 0.596 
Limiting long-standing illness   0.001 
      Yes 587 (26.6) 829 (31.0)  
      No 1616 (73.4) 1845 (69.0)  
Depressive symptoms (CES-D) 0.6 (1.3) 1.1 (1.7) <0.001 
Sleep quality  2.1 (0.8) 2.4 (0.9) <0.001 
Sleep duration   <0.001 
     ≤ 6 h 608 (27.6) 919 (34.4)  
     >6-7 h 780 (35.4) 834 (31.2)  
     >7-8 h 673 (30.5) 736 (27.5)  
  >8 h2 142 (6.4) 185 (6.9)  
CRP1 3.0 (4.5) 3.5 (4.7) 0.001 
Fibrinogen  3.3 (0.5) 3.4 (0.5) <0.001 
Verbal fluency 
Verbal memory 
     Immediate recall  
     Delayed recall  
















SD = standard deviation; GCE = General Certificate of Education; BMI = body mass index;  CES-D = Center for 
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CRP = C-reactive protein; CI = confidence interval. *For indirect effect bias corrected 95% 
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CI = confidence interval. *For indirect effect bias corrected 95% confidence intervals are 
reported. Significant effects are denoted in bold.  
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Fig 1. A conceptual figure of the mediation analysis of inflammatory markers (wave 6) 
between baseline sleep quality/duration (wave 4) and follow-up cognitive functioning (wave 
8). 
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